0.57 USD
▲+0.01+2.62%
盘后 0.61 0.00%
2026-09-16
市值
$15.37M
市盈率
—
EPS
-2.12
股息率
—
52 周区间
0.47 – 2.19
成交量
83.51K
Beta
1.00
目标价
—
52W 低 0.4752W 高 2.19
价格走势
公司简介
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company’s late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and Nove...